Metaiodobenzylguanidine (MIBG) imaging is a well-established method for locating intra-and extraadrenal pheochromocytomas. We investigated whether preoperative injection of 123-I-MIBG might be useful for intraoperative staging of chromaffine tumor cells. This was performed in a 46-year-old patient in whom the diagnosis of a malignant pheochromocytoma had been established by 123-I-MIBG imaging and enhanced catecholamine secretion. The rationale for intraoperative staging in this patient was a discrepancy between computed tomography (CI) of the abdomen and the radionuclide imaging, because scintigraphy revealed a mass with MIBG uptake in the right lower abdomen that could not be visualized by CT. We thus applied a preoperative dose of 4 mCi 123-I-MIBG and determined tissue activity by direct organ measurement. A right abdominal mass was thus identified with an activity of 10×104 impulses/s as compared to normal tissue (15×102). The left-sided tumor was found to be identified correctly by prior CT and MIBG imaging. We thus conclude that intraoperative application of this single probe measurement might help to identify chromaffine tumor cells that have not been located fully by CT.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bravo RL, Gifford RW (1984) Current concepts: pheochromocytoma diagnosis, location and management. N Engl J Med 311:1298–1303
Bravo EL, Tarazi RC, Fouad FM, Vidt DG, Gifford RW (1981) Clonidine suppression test — a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 305:623–626
Chatal JF, Charbonnel B (1985) Comparison of iodobenzylguanidine imaging with computed tomography in localizing pheochromocytoma. J Clin Endocrinol Metab 61:769–772
Editorial (1984) Iodobenzylguanidine for localization and treatment of pheochromocytoma. Lancet II:905–907
Fischer M, Vetter W, Winterberg B, Hengstmann J, Zidek W, Friemann J, Vetter H (1984) Scintigraphic localization of pheochromocytomas. Clin Endocrinol 20:1–7
Keßel F, Hahn K, Eißner D, Beyer J, Thelen M (1986) 131-Jod-Meta-Jodobenzylguanidin-Szintigraphie und -therapie bei malignem Phäochromozytom. Internist 27:70–73
Lehnert H, Walger P (1985) Plasma 3-methoxy-4-hydroxyphenethylenglycol in pheochromocytoma. Cardiology [Suppl 1] 72:160–162
Nakajo M, Shapiro B, Lopp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH (1983) The normal and abnormal distribution of the adrenomedullary imaging agent 131-I-MIBG in man: evaluation by scintigraphy. J Nucl Med 24:672–676
Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, Carey JE, Swanson DP, Copp JE, Satterlee WG, Wieland DM (1984) Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med 25:197–206
Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R (1978) Localization of pheochromocytoma by computed tomography. N Engl J Med 299:460–461
Taylor HC, Mayes D, Anton AH (1986) Clonidine suppression test for pheochromocytoma: examples of misleading results. J Clin Endocrinol Metab 63:238–242
Wieland DM, Wu JL, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH (1980) Radiolabelled adrenergic neuroblocking agents: adrenomedullary imaging with iodobenzylguanidine. J Nucl Med 21:349–353
About this article
Cite this article
Lehnert, H., Weber, P., Nägele-Wöhrle, B. et al. Intraoperative localization of malignant pheochromocytoma by 123-i-metaiodobenzylguanidine single probe measurement. Klin Wochenschr 66, 61–64 (1988). https://doi.org/10.1007/BF01713012
- MIBG scintigraphy
- Intraoperative staging